Advances in oral therapy for multiple myeloma

Conventional intravenous chemotherapy regimens are toxic, cumbersome, and negatively affect patients' quality of life, with oral treatment preferable to most patients with cancer. Multiple myeloma is the second most common haematological malignant disease, but cannot be cured with conventional...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The lancet oncology 2006-04, Vol.7 (4), p.316-325
Hauptverfasser:	Morgan, Gareth J, Krishnan, Biju, Jenner, Matthew, Davies, Faith E
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Bone marrow Cancer therapies Catheters Chemotherapy Cytotoxicity Drug dosages Enzyme Inhibitors - administration & dosage Enzyme Inhibitors - adverse effects Enzyme Inhibitors - therapeutic use Fibroblasts Hematology Humans Immunologic Factors - administration & dosage Immunologic Factors - adverse effects Immunologic Factors - therapeutic use Insulin-like growth factors Kinases Multiple myeloma Multiple Myeloma - drug therapy Multiple Myeloma - physiopathology Quality of life Signal Transduction Vascular endothelial growth factor Vascular Endothelial Growth Factor A - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!